Publications by authors named "Michael Pursley"

Claim this Profile
A
Avoiding Treatment in Hospital With Subcutaneous Furosemide for Worsening Heart Failure: A Pilot Study (AT HOME-HF).
Marvin A Konstam, Joseph Massaro, Ravi Dhingra, Mary Walsh, Linda Ordway, Michael S Pursley

JACC Heart Fail· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bicuspid Aortic Valve Endocarditis Caused by Streptococcus sanguinis: A Case Report.
Sravani Singu, Robert Chory, Vamsi K Singu, Michael Pursley, Glenn Harris

Cureus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.
Connie N Hess, Judith Hsia, Ian A Carroll, Mark R Nehler, Wolfram Ruf, Michael S Pursley

Arterioscler Thromb Vasc Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidental Finding of Thoracic Aortic Dissection in a Patient Post-Coronary Artery Bypass Graft Surgery.
Aniekeme S Etuk, Celestine I Odigwe, Sravani Singu, Emmanuel O Amoran, Michael Pursley

Cureus· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Takotsubo Cardiomyopathy Precipitated by Gastrointestinal Bleeding: Review of the Pathophysiology.
Aniekeme S Etuk, Celestine I Odigwe, Christabel Nyange, Stanley Thornton, Michael Pursley

Cureus· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Michael E Nassif, Sheryl L Windsor, Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah, Michael Pursley

Nat Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
Mikhail N Kosiborod, Russell Esterline, Remo H M Furtado, Jan Oscarsson, Samvel B Gasparyan, Michael Pursley

Lancet Diabetes Endocrinol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
Michael E Nassif, Sheryl L Windsor, Fengming Tang, Yevgeniy Khariton, Mansoor Husain, Michael Pursley

Circulation· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors.
Sapna Sinha, Michael H Pursley, Duane P Grandgenett

J Virol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis